Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical needs. They are dedicated to bringing hope to millions of patients by creating new pathways to smarter medicine and optimizing therapeutic treatments.

Nektar Therapeutics (NASDAQ:NKTR) down -2.04% to close at the price of $49.56. Nektar Therapeutics (NASDAQ:NKTR) has an ABR of 1.29 which is the

Nektar Therapeutics · @NektarNews. ·. Nov 3, 2022. At #ASH2022, Nektar is presenting data and a new clinical study design for NKTR-255, our novel, polymer ...

Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet ...

Nektar Therapeutics

Find contacts at this company